Amarin's Omega-3 Fair Trade Complaint Questions US Dietary Ingredient Standards

Amarin's recent fair trade complaint targetting purified EPA dietary supplements and formulations also raises broader questions about using synthetic dietary ingredients in consumer supplements and the extent to which a substance’s identification in an IND precludes subsequent use as a dietary ingredient.

A pharmaceutical firm’s fair trade complaint targeting purified eicosapentaenoic acid (EPA) dietary supplements or omega-3 formulations containing primarily EPA in ethyl ester or re-esterified raises a broader issue of concern to supplement marketers: FDA's criteria for allowing the use of certain ingredients in supplement products.

Amarin Corp. PLC’s complaint filed on Aug. 30 with the US International Trade Commission more narrowly could affect the...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Approval Standards

More from Pathways & Standards